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A total of 200 freshly voided goat faeces samples were collected in the study and were examined for the 
presence of thermophilic Campylobacter spp. The samples were obtained randomly from 2 farm 
settlements in Venda region, South Africa in 2008 to 2009. All samples were analyzed with the mCCDA 
media with Campylobacter supplement in microaerophilic condition provided by the Campygen gas 
envelope (Oxoid). Of the total 200 samples, the recovery rate was 29% (58 of 200) for all samples. Of the 
200 samples, 155 (77.5%) were non-diarrheic and 45 (22.5%) were diarrheic faeces. From the 45 diarrheic 
faces, 41 (91.1%) were positive for campylobacters and of the 155 non-diarrheic faeces, 17 (11.1%) were 
positive for campylobacters. In all, 58 Campylobacter species comprising 33 (56.9%) Campylobacter 
jejuni and 8 (13.9%) Campylobacter coli strains were from diarrheic and 2 (3.4%) C. jejuni and 15 (25.9%) 
C. coli were from non-diarrheic faeces. There was no statistical correlation between the incidence of C. 
jejuni in diarrheic faeces and non-diarrheic faeces. Rate of resistance of C. jejuni and C. coli to six 
regularly used antibiotics in human and veterinary campylobacteriosis; ciprofloxacin, gentamycin, 
ampicillin, tetracycline, nalidixic acid and erythromycin were 40.0, 47.1%, 57.1, 43.5%, 48.6, 56.5%, 42.9, 
43.5%, 34.3, 34.5% and 14.3, 17.4%, respectively. In comparison, a significantly higher frequency of 
resistance to gentamycin was recorded among the C. jejuni and C. coli isolates (57.1 versus 43.5%) 
respectively, at p < 0.005 from goats in all farms. Resistance to ciprofloxacin and kanamycin was higher 
among the C. coli than C. jejuni strains but the difference was not statistically significant. Comparable 
occurrences of resistance were observed among C. jejuni and C. coli to erythromycin and nalidixic acid. 
High prevalence of thermophilic Campylobacter spp. in goat could be of public health significance in the 
Venda region. The observed multi-drug resistance and especially resistance to macrolides and 
fluoroquinolones in this study pose a threat of transfer of antibiotic resistance to human pathogens 
because of the close contact between goats and man. 
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During the past decade, Campylobacter jejuni has been 
recognized as a major cause of human gastroenteritis. In 
several developed countries the incidence of 
campylobacteriosis exceeds that of salmonellosis 
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studies revealed that campylobacteriosis accounts for 
approximately 12% of all the cases of  acute human 
gastroenteritis (Hoogenboom-Verdegaal et al., 1989). 
Foods of animal origin may serve as vehicles of infection 
(Blaser et al., 1984). In many reports, an asso-ciation has 
been made between campylobacteriosis and recent 
consumption of raw or undercooked poultry meat (El-
Shenawy and Marth, 1989; Oosterom et al., 1984). Up till 





poultry flocks are still unclear. Several factors suspected 
to be sources or vectors of infection have been the 
subjects of studies. Kazwala et al. (1990) suggested that, 
flocks were most likely infected from  the environment of 
the poultry houses.   
In Nigeria, small ruminants (sheep and goats) con-
stitute about 35% of the total meat supply (FAO, 1995; 
Salihu et al., 2009). Sheep and goats have played very 
important role in offsetting the protein deficiencies which 
are fairly rampant in the country.  There is a growing 
appreciation of the importance of goats in small-scale 
integrated farming system in developing countries 
(Devendra and Mcleroy, 1992). In most developing 
countries, goats with cattle, sheep and poultry with very 
poor veterinary inputs and hygiene are reared. The hus-
bandry systems under which goats are reared in Sokoto, 
Nigeria, bring them in close contact with humans and 
other animals including dogs and cats (Salihu et al., 
2009). This system of rearing is a common practice in 
developing countries especially in African countries 
where animal rearing is a common source of protein and 
income. Campylobacters have been reported among 
healthy and diseased farm animals in Nigeria and Tanzania 
(Olubunmi and Adeniran, 1986; Jiwa et al., 1994; Raji et 
al., 2000). It has also been reported in raw milk, goats 
and cattle in Europe and several other countries (Oporto 
et al., 2009; Anderson et al., 2006; Baserisalehi et al., 
2007; Suzuki and Yamamoto, 2009).  Salihu et al. (2009) 
in their study in Sokoto, Nigeria, noted that 20% of the 
goat faecal droppings contain Campylobacter spp. A 
prevalence study recently carried out in the Basque 
country (Northern Spain) identified 28.3% (34/120) of 
ovine and 18.0% (37/206) of bovine farms positive for C. 
jejuni (Oporto et al., 2007) and even higher values 
(38.2%, 13/34) in free-range poultry farms (Esteban et 
al., 2008). The natural habitat of most Campylobacter 
spp. is the intestine of birds and other warm-blooded 
animals, including seagulls and several other wild birds 
(Kapperud and Rosef, 1983). Campylobacteriosis is 
primarily a food-borne disease, because of its low infective 
dose, it has been estimated that 500 cells of C. jejuni can 
cause human illness (Black et al., 1988). From this, it is 
clear that even small number of Campylobacter cells in 
water or food due to faecal contamination may be a 
potential health hazard (Salihu et al., 2009).   
Sporadic abortion due to campylobacteriosis has been 
reported in sheep and goats although goats are known to 
be more resistant to Campylobacter infections resulting in 
fewer abortions (Moeller, 2009). The three species of 
Campylobacter adjudged to cause abortion are 
Campylobacter fetus, C. jejuni and Campylobacter lari. 
Campylobacter infections most often cause late term 
abortions, stillbirths, or the birth of weak non-viable 
lambs/ewe (Moeller, 2009).  
Recently, the concern for this foodborne infection has 
increased because of the frequent isolation of 
antimicrobial resistant strains in humans and animals 
(Aarestrup and Wegener, 1999). This  is  a  consequence 




of the massive use of antibiotics in modern intensive 
animal production for therapy and prevention of diseases, 
as well as use of same  as  growth  promoters.  Hence, food 
animal origin may represent a vehicle of transmission of 
resistant Campylobacter spp. to humans. This applies 
particularly for strains resistant to quinolones and 
erythromycin, widely used for therapy in human systemic 
infections or in severe long-lasting cases of enteritis 
(Aarestrup and Engberg, 2001; Pezzotti et al., 2003). 
However, there was stability pattern in resistance 
between 1997 and 2001 with a value of 2%. Bywater et 
al. (2004) in their study of incidence of Campylobacter in 
chicken, cattle and pig and their antimicrobial resistance, 
observed differential resistance to ciprofloxacin of 
Campylobacter coli and C. jejuni isolated from chicken 
with a prevalence of 39.6 to 14.9%, respectively. In all the 
tests, they observed higher resistance of C. coli over C. 
jejuni to nalidixic acid (39.6, 15.1%), erythromycin (13.6, 
1.0%) and tetracycline (58.4, 35.4%). The trend was the 
same for all the isolates from cattle and pig with C. coli 
showing higher resistance to the aforementioned 
antibiotics. Pezzotti et al. (2003) in their study of chicken 
and pork meat noted higher resistance of isolated C. coli 
and C. jejuni to ten selected antibiotics. Percentage of 
resistance of chicken isolates was 78.6 and 52.8 for 
enfloxacin, 78.5 and 52.8 for ciprofloxacin, 78.6 and 59.7 
for nalidixic acid, 48.2 and 31.9 for tetracycline, 25.0 and 
12.5 for erythromycin, and 30.4 and 5.6 for streptomycin. 
For pork meat, resistance trend were similar with C. coli 
showing more resistance to the antibiotics than C. jejuni, 
with exception of gentamycin, where C. jejuni resistance 
was 1.4% and all C. coli isolates were susceptible. 
The risk factors associated with the infection include 
occupational exposure to farm animals, consumption of 
raw milk or milk products and unhygienic food preparation 
practices (Alterkruse et al., 1999). It has been reported 
that difficulty in Campylobacter detection is responsible 
for deficiency in the accurate information concerning 
Campylobacter infection in developing countries 
(Baserisalehi et al., 2006, 2007), but Campylobacter is 
hyper-endemic in developing countries (Salihu et al., 
2009). Added to this, is the fact that there is lack of 
surveillance and database relating to prevalence of 
Campylobacter organisms in developing countries. While 
the incidence and prevalence of campylobacters have 
been reported extensively in developed nations among 
other animals, there is a dearth of information on the 
shedding patterns of Campylobacter spp. by goats in 
developing nations, South Africa inclusive. This study 
was intended to determine the prevalence, pathological 
indices and antibiotic susceptibility profiles of 
Campylobacter species among goats in two farm 
settlements in Venda region, South Africa. 
 
 
MATERIALS AND METHODS 
 
Description of the farm settlements 
 
The farm settlements were separated from each other by  about  80  




Table 1. Data analysis of information obtained from the goat farms in Venda region, Limpopo 
province South Africa. 
 
Total number of faece 
Number Percentage (%) 
200 100 
Number of diarrheic faeces 45 22.5 
Number of non-diarrheic faeces 155 77.5 
Positive diarrheic faeces 41 91.1 
 
Campylobacters isolated 
C. jejuni 35 17.5 
C. coli 23 11.5 
No. -haemolytic 55 94.8 




Km and apart from goats other farm animals co-reared were cattle, 
sheep and chicken. The farms were each located about 500 m from 
the stream from which the animals drink water and which also serve 
as water supply for the community. Hence, runoffs after heavy 
rainfall are capable of contaminating this surface water that serve 






A total of 200 faecal samples were collected from apparently 
healthy and observed diarrheagenic goats from two farm settle-
ments named X and Y for ethical reasons from the Venda region in 
the Limpopo province, South Africa, over a period of six months. 
Freshly voided faeces were collected aseptically in sterile collection 
tubes, refrigerated in cooler packed with ice and were transported 
to the laboratory within 1 h of collection. The samples were 
inoculated directly on mCCDA to which the selective supplement 
had been added and incubated at 42°C for 48 h under micro-
aerophilic condition using Campygen (Oxoid, CM739, SR 155E, CM 
025) (Oxoid Ltd, Basingstoke, RG24 8PW, U.K). This temperature 
was used for the specific isolation of thermophilic pathogenic 
Campylobacter species.  
From the positive agar plates, 2 to 3 colonies showing typical 
Campylobacter features were selected and subcultured and 
thereafter, were tested for gram-staining, motility, production of 
oxidase and catalase. These isolates were stored in brain heart 
infusion agar (BHA) with 15% (V/V) glycerol at -20°C prior to further 
characterization. Agglutination tests using Campylobacter dryspot 
(specific for thermophilic Campylobacter species and Mast 
diagnostic test (specific for C. jejuni, C. coli and C. lari) were done 
according to the manufacturer’s instruction. The dryspot 
Campylobacter test kit (agglutination test for pathogenic 
Campylobacter strains of C. jejuni, C. coli, Campylobacter 
upsaliensis and C. lari) was used in conjunction with Mast 
diagnostic method which incorporates biochemical tests involving 
test for hippurate hydrolysis, indoxyl acetate hydrolysis and urea 
hydrolysis through the urease system. The Oxoid agglutination and 
Mast tests were done according to the manufacturer’s instruction. 
Agglutination under normal lighting condition is indicative of 
Campylobacter and belongs to any of the four species mentioned 
earlier (Baker et al., 2006; Chaban et al., 2010). The result from the 
Mast tests enables speciation of the Campylobacters isolates. The 
number of faeces samples (diarrheic and non-diarrheic) positive for 
Campylobacter and the number of C. jejuni and C. coli is shown in 
Table 1. 
PCR confirmation of Campylobacter 
 
Genomic DNA was obtained by the whole-cell lysate method as 
described by Marshall et al. (1999). In order to ascertain if the 
dryspot/Mast diagnostic kit positive Campylobacter isolates were 
actually campylobacters, they were subjected to PCR identification 
using the general primers for the identification of campylobacteria.  
However, Arcobacter and Helicobacter spp. showed negative 
reaction to the Campylobacter dryspot kit. Hence, any amplification 
of the primer sequences at the 1,004 bp fragment within the coding 
region of 16S rRNA confirmed that, such isolates are 
Campylobacter spp. and not Helicobacter or Arcobacter spp. 
Oligonucleotides primers employed in this study were CAH16S 1a 
(5’ – AAT ACA TCA AAG TCG AAC GA – 3’) and CAH16S 1b (TTA 
ACC CAA CAT CTG ACG AC – 3’), respectively. The 
oligonucleotides used in this study were synthesized by Inqaba 
Biotechnologies (Pretoria, South Africa). The micrograph of the 





To ascertain the pathogenic status of the isolates, the 
Campylobacter spp. was subjected to haemolytic test according to 
the procedure of Samie et al. (2006). Briefly, a 24 h broth culture of 
Campylobacter spp. was cultured by spread plate method on 
Columbia agar supplemented with sheep blood. Plates were 
incubated at 35°C for 24 h.  
Thereafter, plates were observed for complete haemolysis and 
partial haemolysis. The haemolytic profile is shown in Table 2.  
 
  




The antibiotics tested in this study were: trimethroprim (2.5 µg), 
nalidixic acid (30 µg), ciprofloxacin (5 µg), gentamycin (10 µg), 
tetracycline (30 µg), ampicillin (10 µg), erythromycin (15 µg), 
streptomycin (10 µg), methicillin (µg), cefexime (30 µg), imipenem 
(µg), kanamycin (30 µg) and vancomycin (30 µg) (Oxoid, Unipath 
Ltd, Basingstoke, England). However, attention was paid more to 
the relevant antibiotics used for human and veterinary 
campylobacteriosis, since these antibiotics are used in cases of 
campylobacteriosis in humans. Some tetracycline is used as growth 
promoters in veterinary. 








C. jejuni C. coli 
Number tested (35) percent resistant (%) Number tested (23) percent resistant (%) 
Ciprofloxacin 40.0 47.8 
Tetracycline 42.9 43.5 
Ampicillin 48.6 56.5 
Gentamycin 57.1 43.5 
Erythromycin 14.3 17.4 
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Figure 1.  PCR products of the amplified DNA from goats Campylobacter isolates aligning at the 1004 bp of 




Antimicrobial susceptibility testing 
 
The method of Gaudreau and Gilbert (1997) was used. Briefly, the 
confirmed Campylobacter  isolates  were  inoculated  into  plates  of 
Mueller-Hinton agar plates carrying a minimum of five discs. All 
plates were incubated at 35°C under a microaerophilic atmosphere 
obtained with a gas generator envelope (Oxoid), for 24 h. The 
resulting zone diameters were measured with a graduated metre 
rule. Analysis of diameter was done according to the procedural 





Two hundred (200) freshly voided goat faeces samples 
were analyzed in the study. The rate of recovery of 
Campylobacter was 29.0% (58 of 200) for all the cases. 
Of these, 91.1% (41 of 45) were from diarrheic and 
11.1% (17 of 155) were from non-diarrheic faecal 
samples.  Overall, 58 Campylobacter species comprising 
of 33 (56.9%) C. jejuni and 8 (13.9%) C. coli strains were 
isolated from diarrheic and 2 (3.4%) C. jejuni and 15 
(25.9%) C. coli strains were isolated from non-diarrheic 
faeces (Table 1). There was a higher prevalence of C. 
jejuni in diarrheic faeces than C. coli and vice versa. The 
high incidence rate of C. jejuni in diarrheic faeces is an 
indication that the  campylobacteriosis  witnessed  among  
the  goats  in these farms had their origin from C. jejuni 
infection. This could lead to abortion and stillbirth among 
goats and a substantial economic loss to the rearers. 
There was a high incidence of C. coli compared with C. 
jejuni in the non-diarrheic faeces; a result that confirmed 
that the diarrhea noticed in the goats may have been 





Out of the 58 Campylobacter isolates tested for 
haemolysis, 55 (94.85) were - haemolytic and 3 (5.1%) 
were -haemolytic. None of the isolates was non-





The PCR studies of the 16S rRNA fragment of 
Campylobacter DNA showed that the DNA fragment was 
aligned at 1004 bp (Figure 1).  




























Figure 2. Susceptibility profiles of 90 strains of C. jejuni and C. coli by disc diffusion using six popularly employed 







Figure 2 shows the sensitive, intermediate and resistance 
profile of the 58 Campylobacter isolates exposed to six 
antibiotics employed in veterinary and human 
campylobacteriosis according to CLSI (2010) guidelines. 
The strains were more sensitive to erythromycin 
(macrolide) than the rest antimicrobials and were more 
resistant to gentamycin and ampicillin. On the basis of 
species resistance, C. coli isolates were more resistant to 
the six antibiotics. Individually, there was a high rate of 
resistance to some or all of the antibiotics. The rate of 
resistance of C. jejuni and C. coli to these antibiotics; 
ciprofloxacin, gentamycin, ampicillin, tetracycline, 
nalidixic acid and erythromycin were (40.0, 47.1%), (54.3, 
60.9%), (57.1, 43.5%), (48.6, 56.5%), (42.9, 43.5%), 
(34.3, 34.5%) and (14.3, 17.4%), respectively. In 
comparison, a significantly higher frequency of resistance 
to gentamycin was recorded among C. jejuni and C. coli 
isolates (57.1 versus 43.5%), respectively, at p < 0.005 
from goats in all the farms (Table 2). Similarly, resistance 
to ciprofloxacin was higher among C. coli and C. jejuni 
isolates from goats but was not statistically significant (P 
> 0.005). For erythromycin and nalidixic acid, comparable 
occurrences of resistance were recorded among C. jejuni 
and C. coli from all the farms. C. coli isolates had a 
higher rate of resistance to ampicillin (56.5%) than C. 
jejuni (48.6%). Multiple resistances were shown to 
combination of antibiotics by Campylobacter isolates from 
all the farms. For example, 5 (14.3%) C. jejuni were 
resistant to all the six antibiotics, while 8 (34.8%) C. coli 
were also resistant to all the six antibiotics. The rate of 
multiple resistances among the different Campylobacter 
spp is shown in Table 3. The multiple resistances 
witnessed in this study to the antibiotics is of public health 
significance as these multiple antibiotic resistant strains 
are capable of being disseminated into the wider 
environment to constitute source of acquisition of 





In this study, 29% (58 out of 200 animals) of the goats 
sampled were found to harbor Campylobacter isolates in 
their faeces. In a study done in Sokoto State, Nigeria, on 
1312 faecal samples, over a period of 2 years, Salihu et 
al. (2009) found 20% of the faecal samples to be positive 
for Campylobacter.  This presence and high prevalence 
of Campylobacter in goat is of serious concern in view of 
the high rate of consumption of goat meat in most African 
countries. This prevalence value is low when compared 
with reported prevalence rates in other food animal by 
several workers (Stanley and Jones, 2003; Sato et al., 
2004; Workman et al., 2005; Verma et al., 2005; 
Baserisalehi et al., 2007; Uaboi-Egbenni et al., 2008). 
Few available studies have reported heavy shedding of 
Campylobacter among goats (Salihu et al., 2009). In this 
study, most Campylobacters isolated were from diarrheic 
faeces, although, few mainly C. coli and C. jejuni were 
also isolated from non-diarrheic faeces. More C. jejuni 
(60.4%) were isolated than C. coli (39.6%). This 
observation is in line with the report of Salihu et al. (2009) 
in Nigeria.  However, the studies done in northern Nigeria 
on sheep showed a high prevalence of C. coli than C. 
jejuni.  








C. jejuni C. coli Campylobacter spp. 
Number of strain Strain (%) Number of strain Strain (%) Number of strain Strain (%) 
C,T,E,N,G,A 5 14.3 8 34.8 13 22.4 
C, T 6 17.1 7 30.4 13 22.4 
C, T, N 7 20.0 11 47.8 18 31.0 
G, A 7 20.0 11 47.8 18 31.0 
 




Although, there is paucity of reports on 
campylobacteriosis in goats, similar work done on other 
food animals have indicated enteritis and stillbirth in 
sheep (Dennis, 1990; Koides, 1991; Raji et al., 2000), 
new born calves (Padungton and Kareene (2003).  
Bywater et al. (2004) reported high prevalence of 
Campylobacter among chicken in France and UK (50 and 
70%), in cattle in Germany and UK (66 and 50%) and 
pigs in France, Spain and UK (50, 42 and 35%). These 
variations in prevalence rate from one country to another 
shows discrepancies in the prevalence of Campylobacter 
spp. among different animals and may be a reflection of 
geographic factors and/or differences in strategies to 
monitor antibiotic use in different countries. Kimberly 
(1988) reported Jenson and Swiff’s diseases of sheep in 
Philadelphia, LA, USA, resulting from campylobacteriosis 
caused by C. jejuni and its pathogenic allies. While 
disease conditions resulting from Campylobacter 
infections have been well studied in other farm animals, 
the nature of disease conditions in goats is still shrouded 
in obscurity.  
Campylobacter have also been described in goat meat. 
In a recent study in Iran, the highest prevalent of 
Campylobacter spp was found in lamb meat (12.0%), 
followed by goat meat (9.4%), beef meat (2.4%) and 
camel meat (0.9%) (Rahimi et al., 2010). 
Studies of pathological indices of the Campylobacter 
isolates revealed that of the 58 Campylobacter isolates, 
55 (94.8%) were -haemolytic, while 3 (5.2%) were -
haemolytic. This finding support the studies of Samie et 
al. (2007) in Vhembe district on HIV/AIDS patients where 
they observed a high prevalence of -haemolytic C. 
jejuni. These animals may have served as source of 
infection of human population via contamination of 
surface and subsurface bodies of water in the Vhembe 
region. 
Resistance to fluoroquinolones and macrolides has 
shown a tremendous increase over the past two decades 
(Saenz et al., 1997; Prats et al., 2000; Reina et al., 1994). 
Quinolone resistance and to a lesser extent, macrolide 
resistance of Campylobacter isolates from the production 
of animals are now recognized as emerging public health 
problems (Engberg et al., 2001; Châtre et al., 2010; 
Smith and Fratamico, 2010). Result from recent 
susceptibility studies of C. jejuni and C.  coli  from  poultry 
meat performed in different countries indicated 
substantial variations between countries.  Relatively high 
resistance rates in C. jejuni strains isolated from chicken 
meat were reported from Belgium (Van Looveren et al., 
2001; Habib et al., 2009), United States (Ge et al., 2003) 
and Italy (Pezzotti et al., 2003; Rollo et al., 2010), 
moderates were reported from Switzerland (Ledergerber 
et al., 2003; Korczak et al., 2009) and northern Ireland 
(Wilson, 2003), whereas, limited occurrences of anti-
microbial resistance among C. jejuni was reported from 
Sweden (Lindmark et al., 2004). A possible explanation 
for these differences might be that, occurrences of 
antimicrobial resistance are reflecting the different 
national and regional policies in relation to the use of 
antimicrobial agents for food animals. Although, there is a 
paucity of information on the antimicrobial susceptibility of 
Campylobacter isolates from goats on antibiotics to make 
effective comparison, various studies are available on the 
susceptibility profiles of Campylobacter isolates from 
other food animals and small ruminants. 
Resistance of C. jejuni and C. coli to ciprofloxacin, 
tetracycline, nalidixic acid and erythromycin antibiotics in 
several food animals have been reported by other 
workers: cattle, sheep and poultry faeces (de Jong et al., 
2009; Oporto et al., 2009; 2007; Sahin et al., 2008; 
Zweifel et al., 2004; Englen et al., 2005; EFSA, 2007), in 
swine (Oporto et al., 2007) and from poultry farms 
(Esteban et al., 2008). The resistance shown by 
Campylobacter isolates from goats to functional anti-
biotics used for human and veterinary campylobacteriosis 
has high public health significance. It brings to question if 
man has actually been able to unrivalled the various 
sources of antimicrobial resistance in animals and in the 
environment. The occurrence of high resistance to 
antibiotics among Campylobacter isolates from goats in 
this study need further investigation more so as no report 
on antibiotic susceptibility profile from goats has hitherto 
been reported. 
In this study, we found significant difference in tetra-
cycline resistance between C. jejuni and C. coli isolates. 
This observation is in line with the findings of Ge et al. 
(2003) who found that Campylobacter isolated from 
turkey meat showed high resistance than those from 
chicken meat. Similarly, Oporto et al. (2009) in their 
study,    observed     significantly    high     resistance    of  




Campylobacter isolated from sheep to those isolated 
from beef cattle and poultry but less significant value 
among those isolated from sheep and those from dairy 
cattle. Gibreel and Taylor (2006) in their review reported 
varied rates of resistances of C. jejuni and C. coli to 
erythromycin among human isolates in several countries. 
A high prevalence of resistance to most of the antibiotics 
was observed among C. coli isolates than C. jejuni 
isolates. Gibreel and Taylor (2006) observed a high 
prevalence of resistance among C. coli than C. jejuni 
isolated from cattle and pigs to tetracycline, ciprofloxacin 
and nalidixic acid. Similarly, these workers reported 
higher prevalence among C. coli than C. jejuni isolates 
from pigs and chicken to erythromycin, but higher 
prevalence of resistance in C. jejuni than C. coli isolates 
from cattle to erythromycin. They did not observe 
resistance to gentamycin in all their isolates except for 
0.7% observed with C. jejuni and 0% for C. coli from 
cattle. In this study, the most stable antibiotic to the 
campylobacters isolated from goats in all the farms was 
erythromycin. This finding is in line with the observation 
of Bywater et al. (2004) who reported as low as between 
1 to 2% resistance of Campylobacter spp. isolated from 
chicken, cattle and pigs. 
The high prevalence of resistance to nalidixic acid, 
ciprofloxacin and tetracycline of Campylobacter spp. 
isolated from goats could be of public health importance. 
This is so, because  a number of investigations from the 
United States, Thailand and Denmark have shown that 
infections with macrolide-resistant Campylobacter 
isolates could be associated with an increased risk of 
adverse events, development of invasive illness or death 
compared with infections with drug susceptible isolates 
(Travers and Barza, 2002;Helms et al., 2005). The root of 
entry of the antibiotic-resistant campylobacters to goats 
has not been elucidated. Speculatively, the pastures on 
which these animals graze as well as surface waters from 
which they drink are likely sources of acquisition of these 
resistant strains of these campylobacteria. The isolation 
of fluoroquinolone, quinolone and macrolide-resistant 
Campylobacter species in goats has again stressed the 
need for proper surveillance of the use of antibiotics not 
only as growth promoters but as therapeutic use in 
veterinary medicine. There is also the need to monitor the 
emergence of resistant strains in order to develop new 
and effective antibiotics against campylobacteriosis.  This 
will further protect man from acquisition of antibiotic-






The study reported relatively high prevalence of 
Campylobacter species among goats in farms in South 
Africa. We also reported the isolation of Campylobacter 
species more from diarrheic than non-diarrheic faeces. C. 





C. coli. This study indicated that, goats can act as source 
of human infections as well as contamination of the wider 
environment. The isolation of fluoroquinolone, quinolone 
and macrolide-resistant Campylobacter species in goats 
has again stressed the need for proper surveillance of the 
use of antibiotics not only as growth promoter but as 
therapeutic use in veterinary medicine. There is also the 
need to monitor the emergence of resistant strains in 
order to develop new and effective antibiotics against 
campylobacteriosis. This will further protect man from the 
acquisition of antibiotic-resistant Campylobacter strains 
from goat and the wider environment. The dissemination 
of these Campylobacter organisms in faeces could result 
in an epidemic, if concerted efforts are not made to 
address the origin and cause of the observed prevalence. 
Excreted faeces when passed into the bodies of water 
and pastures could spread to other animals and humans 
that use such water as source of water supply for 
drinking. Based on the location of the farms (close to 
community stream) and coupled with the fact that other 
animals are reared together, we would have on our hand 
an epidemic situation which may be difficult to curtail if 
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